Share: Facebook Twitter LinkedIn
Activity Provided By:


Spotlight on IRON CLAD: Clinical Review of IV Iron Replacement Therapy for Cancer-and Chemotherapy-Induced Anemia

Access Activity

Overview / Abstract:

This quick, comprehensive video will review the diagnosis and treatment of cancer- and chemotherapy-induced anemia (CIA). Expert faculty, Dr. Jeffrey Gilreath from University of Utah Hospitals and Clinics
will discusses the role of intravenous (IV) iron replacement monotherapy, including ferric carboxymaltose (FCM), recent clinical trial data supporting its benefit in treatment of CIA, and management of adverse events in patients receiving this therapy.


Mar 25, 2023


Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME


Webinar / Webcast / Video

Credits / Hours




Presenters / Authors / Faculty

Jeffrey Gilreath, PharmD
Clinical Professor of Pharmacy
Department of Pharmacotherapy
Clinical Hematology/Oncology Pharmacist
University of Utah Hospitals and Clinics
Salt Lake City, UT

Activity Specialities / Related Topics

Hematology, Oncology / Cancer / Radiation Therapy

Sponsors / Supporters / Grant Providers

Supported by an educational grant from American Regent, Inc.

Keywords / Search Terms

ACHL IRON CLAD, anemia, iron deficiency, chemotherapy, blood transfusion, iv iron, chemotherapy induced anemia, CIA, Jeffrey Gilreath, PharmD, CME, CE, Webcast, University of Utah Hospitals and Clinics Free CE CME

Access Activity

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map